AKRO
Price
$54.28
Change
+$0.34 (+0.63%)
Updated
Jun 6 closing price
Capitalization
4.31B
62 days until earnings call
DOSEF
Price
$0.36
Change
-$0.02 (-5.26%)
Updated
Jun 4 closing price
Capitalization
1.63M
Interact to see
Advertisement

AKRO vs DOSEF

Header iconAKRO vs DOSEF Comparison
Open Charts AKRO vs DOSEFBanner chart's image
Akero Therapeutics
Price$54.28
Change+$0.34 (+0.63%)
Volume$1.47M
Capitalization4.31B
Doseology Sciences
Price$0.36
Change-$0.02 (-5.26%)
Volume$3.05K
Capitalization1.63M
AKRO vs DOSEF Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. DOSEF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Buy and DOSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (AKRO: $54.28 vs. DOSEF: $0.36)
Brand notoriety: AKRO and DOSEF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 88% vs. DOSEF: 63%
Market capitalization -- AKRO: $4.31B vs. DOSEF: $1.63M
AKRO [@Biotechnology] is valued at $4.31B. DOSEF’s [@Biotechnology] market capitalization is $1.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileDOSEF’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • DOSEF’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than DOSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 6 TA indicator(s) are bullish.

  • AKRO’s TA Score: 6 bullish, 4 bearish.

Price Growth

AKRO (@Biotechnology) experienced а +9.33% price change this week, while DOSEF (@Biotechnology) price change was +282.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

AKRO is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($4.31B) has a higher market cap than DOSEF($1.63M). DOSEF YTD gains are higher at: 158.861 vs. AKRO (95.111). DOSEF has higher annual earnings (EBITDA): -261.38K vs. AKRO (-247.37M). AKRO has more cash in the bank: 743M vs. DOSEF (931K). DOSEF has less debt than AKRO: DOSEF (0) vs AKRO (36.5M). DOSEF has higher revenues than AKRO: DOSEF (58.3K) vs AKRO (0).
AKRODOSEFAKRO / DOSEF
Capitalization4.31B1.63M264,496%
EBITDA-247.37M-261.38K94,643%
Gain YTD95.111158.86160%
P/E RatioN/AN/A-
Revenue058.3K-
Total Cash743M931K79,807%
Total Debt36.5M0-
FUNDAMENTALS RATINGS
AKRO: Fundamental Ratings
AKRO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
52
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKRO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QDEF72.820.51
+0.71%
FlexShares Quality Dividend Defensv ETF
KTEC16.150.03
+0.19%
KraneShares Hang Seng TECH ETF
TINT29.26N/A
N/A
ProShares Smart Materials ETF
IBTH22.30-0.06
-0.27%
iShares iBonds Dec 2027 Term Tr ETF
MPA10.77-0.06
-0.55%
Blackrock Muniyield Pennsylvania Quality Fund

DOSEF and

Correlation & Price change

A.I.dvisor tells us that DOSEF and MNPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DOSEF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOSEF
1D Price
Change %
DOSEF100%
N/A
MNPR - DOSEF
24%
Poorly correlated
-2.38%
AKRO - DOSEF
23%
Poorly correlated
+0.63%
SGMT - DOSEF
21%
Poorly correlated
+16.32%
ADAG - DOSEF
21%
Poorly correlated
+4.74%
CLRPF - DOSEF
12%
Poorly correlated
+0.32%
More